| Literature DB >> 33318340 |
Jeonghwan Lee1,2, Yong Chul Kim2,3, Soie Kwon3, Lilin Li1,4, Sohee Oh5, Do Hyoung Kim6, Jung Nam An7, Jang-Hee Cho8, Dong Ki Kim2,3, Yong-Lim Kim8, Yun Kyu Oh1,2, Chun Soo Lim1,2, Yon Su Kim2,3, Jung Pyo Lee1,2.
Abstract
BACKGROUND: The effect of each health-related quality of life (HRQOL) component on hemodialysis prognosis has not been well studied. We aimed to investigate the clinical factors associated with HRQOL and the effect of HRQOL after dialysis initiation on long-term survival in an Asian population.Entities:
Keywords: Dialysis; Mental health; Mortality; Physical health; Quality of life
Year: 2020 PMID: 33318340 PMCID: PMC7770988 DOI: 10.23876/j.krcp.20.065
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Baseline characteristics according to physical and mental health status
| Variable | Overall (n = 568) | Physical health status | Mental health status | ||||
|---|---|---|---|---|---|---|---|
| Lower group (n = 284) | Higher group (n = 284) | Lower group (n = 284) | Higher group (n = 284) | ||||
| Age (yr) | 60.8 ± 13.5 | 64.0 ± 13.2 | 57.6 ± 13.0 | < 0.001 | 60.5 ± 13.5 | 61.1 ± 13.4 | 0.632 |
| Sex (male) | 350 (61.6) | 166 (58.5) | 184 (64.8) | 0.120 | 182 (64.1) | 158 (55.6) | 0.227 |
| Systolic blood pressure (mmHg) | 144.4 ± 23.2 | 142.4 ± 23.4 | 146.5 ± 22.8 | 0.035 | 144.7 ± 13.9 | 144.1 ± 24.0 | 0.776 |
| Diastolic blood pressure (mmHg) | 77.0 ± 14.2 | 75.2 ± 13.3 | 78.8 ± 14.9 | 0.003 | 77.5 ± 13.9 | 76.5 ± 14.6 | 0.408 |
| Body mass index (kg/m2) | 23.0 ± 3.4 | 22.8 ± 3.5 | 23.3 ± 3.3 | 0.086 | 22.9 ± 3.3 | 23.1 ± 3.5 | 0.472 |
| Primary renal disease | < 0.001 | 0.992 | |||||
| Diabetes mellitus | 323 (56.9) | 193 (68.0) | 130 (45.8) | 163 (57.4) | 160 (56.3) | ||
| Hypertension | 68 (12.0) | 28 (9.9) | 40 (14.1) | 33 (11.6) | 35 (12.3) | ||
| Glomerulonephritis | 91 (16.0) | 33 (11.6) | 58 (20.4) | 45 (15.8) | 46 (16.2) | ||
| Others | 86 (15.1) | 30 (10.6) | 56 (19.7) | 43 (15.1) | 43 (15.1) | ||
| Comorbidities | |||||||
| Coronary artery disease | 75 (13.2) | 45 (15.8) | 33 (11.6) | 0.143 | 41 (14.4) | 37 (13.0) | 0.626 |
| Congestive heart failure | 79 (13.9) | 41 (14.4) | 38 (13.4) | 0.716 | 39 (13.7) | 40 (14.1) | 0.903 |
| Cerebrovascular disease | 51 (9.0) | 34 (12.0) | 17 (6.0) | 0.013 | 24 (8.5) | 27 (9.5) | 0.660 |
| Peripheral vascular disease | 49 (8.6) | 31 (10.9) | 18 (6.3) | 0.052 | 18 (6.3) | 31 (10.9) | 0.052 |
| Modified Charlson comorbidity index | 5.29 ± 2.23 | 5.92 ± 2.27 | 4.65 ± 2.00 | < 0.001 | 5.27 ± 2.23 | 5.30 ± 2.23 | 0.880 |
| Hemoglobin (g/dL) | 8.7 ± 1.7 | 8.8 ± 1.7 | 8.6 ± 1.7 | 0.215 | 8.6 ± 1.7 | 6.2 ± 1.5 | 0.139 |
| Albumin (mg/dL) | 3.7 ± 0.5 | 3.6 ± 0.5 | 3.9 ± 0.4 | < 0.001 | 3.7 ± 0.5 | 3.8 ± 0.4 | 0.501 |
| Calcium (mg/dL) | 7.7 ± 1.1 | 7.8 ± 1.0 | 7.6 ± 1.2 | 0.015 | 7.6 ± 1.1 | 7.7 ± 1.2 | 0.192 |
| Phosphorus (mg/dL) | 5.9 ± 3.7 | 5.9 ± 3.7 | 6.0 ± 2.0 | 0.900 | 6.0 ± 3.5 | 5.9 ± 3.8 | 0.810 |
| Intact PTH (pg/mL, n = 505) | 260.9 ± 207.5 | 221.9 ± 194.9 | 301.0 ± 212.6 | < 0.001 | 261.6 ± 226.4 | 260.1 ± 187.1 | 0.935 |
| Uric acid (mg/dL) | 8.4 ± 2.6 | 8.1 ± 2.6 | 8.6 ± 2.6 | 0.014 | 8.3 ± 2.5 | 8.4 ± 2.6 | 0.642 |
| BUN (mg/dL) | 88.9 ± 37.6 | 84.8 ± 37.5 | 93.1 ± 37.4 | 0.009 | 88.0 ± 39.0 | 89.8 ± 36.2 | 0.580 |
| Creatinine (mg/dL) | 9.16 ± 4.66 | 8.09 ± 4.12 | 10.23 ± 4.93 | < 0.001 | 9.29 ± 4.91 | 9.04 ± 4.40 | 0.525 |
| eGFR (mL/min/1.73 m2) | 6.5 ± 3.4 | 7.3 ± 3.9 | 5.8 ± 2.7 | 0.009 | 6.6 ± 3.6 | 6.4 ± 3.2 | 0.606 |
| Daily urine volume category (n = 401) | 0.008 | 0.013 | |||||
| ≥ 100 mL/day | 149 (75.3) | 174 (85.7) | 144 (75.4) | 179 (85.2) | |||
| 0-100 mL/day | 49 (24.7) | 29 (14.3) | 47 (24.6) | 31 (14.8) | |||
| Urine volume (mL/day, n = 401) | 643.0 ± 543.0 | 603.4 ± 563.9 | 681.5 ± 520.2 | 0.150 | 572.3 ± 493.6 | 707.2 ± 578.0 | 0.013 |
Data are presented as mean ± standard deviation or number (%).
Physical and mental health status was classified by upper and lower half of physical and mental health composite scores.
BUN, blood urea nitrogen; GFR, glomerular filtration rate; PTH, parathyroid hormone.
Figure 1Patient survival according to the kidney disease elements, overall health, and patient satisfaction.
(A) Symptoms/problem list. (B) Effects of kidney disease. (C) Burden of kidney disease. (D) Work status. (E) Cognitive function. (F) Quality of social interaction. (G) Sexual function. (H) Sleep. (I) Social support. (J) Dialysis staff encouragement. (K) Overall health. (L) Patient satisfaction. Among the various elements, lower scores of HRQOL including (B) effects of kidney disease (P = 0.001), (F) quality of social interaction (P = 0.010), (I) social support (P = 0.001), and (J) dialysis staff encouragement (P = 0.028) were significantly associated with poor patient survival. Q1, Q2, Q3, Q4, and Q5 means 3- to 5-quantile group as appropriate.
Risk of kidney disease-related elements of HRQOL on mortality
| Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | ||||
| Effects of kidney disease | 0.013 | 0.014 | |||
| Quartile 1 (reference) | 1 | 1 | |||
| Quartile 2 | 0.436 (0.229-0.830) | 0.012 | 0.407 (0.213-0.778) | 0.007 | |
| Quartile 3 | 0.718 (0.410-1.257) | 0.246 | 0.812 (0.455-1.449) | 0.482 | |
| Quartile 4 | 0.437 (0.242-0.787) | 0.006 | 0.464 (0.248-0.865) | 0.016 | |
| 0.019a | 0.054a | ||||
| Social support | 0.002 | < 0.001 | |||
| 0-33.3 (reference) | 1 | 1 | |||
| 33.3-66.6 | 0.416 (0.206-0.839) | 0.014 | 0.282 (0.135-0.588) | 0.001 | |
| 66.6-100 | 0.178 (0.068-0.463) | < 0.001 | 0.117 (0.042-0.324) | < 0.001 | |
| < 0.001a | < 0.001a | ||||
| Dialysis staff encouragement | 0.042 | 0.011 | |||
| 0-25 (reference) | 1 | 1 | |||
| 25-50 | 0.179 (0.048-0.666) | 0.010 | 0.160 (0.041-0.630) | 0.009 | |
| 50-75 | 0.354 (0.138-0.909) | 0.031 | 0.252 (0.093-0.681) | 0.007 | |
| 75-100 | 0.298 (0.117-0.756) | 0.011 | 0.198 (0.074-0.527) | 0.001 | |
| 0.303a | 0.059a | ||||
CI, confidence interval; HR, hazard ratio; HRQOL, health-related quality of life.
aP for trend.
Figure 2Patient survival according to the physical health domain elements.
(A) Physical function. (B) Physical role limitation. (C) Pain. (D) General health. Among elements in the physical health domain, lower scores of HRQOL including (A) physical function (P < 0.001), (B) physical role limitation (P = 0.002), and (C) pain (P = 0.005) were significantly associated with poor patient survival. Q1, Q2, Q3, Q4, and Q5 means 3- to 5- quantile group as appropriate.
Risk of physical health elements of HRQOL on mortality
| Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | ||||
| Physical function | < 0.001 | 0.029 | |||
| 0-25 (reference) | 1 | 1 | |||
| 25-50 | 0.649 (0.343-1.228) | 0.184 | 0.618 (0.319-1.196) | 0.153 | |
| 50-75 | 0.557 (0.308-1.006) | 0.052 | 0.589 (0.315-1.100) | 0.097 | |
| 75-100 | 0.202 (0.107-0.379) | < 0.001 | 0.323 (0.155-0.675) | 0.003 | |
| < 0.001a | 0.004a | ||||
| Role limitation (physical) | 0.002 | 0.028 | |||
| 0 (reference) | 1 | 1 | |||
| 25-50 | 0.571 (0.326-1.003) | 0.051 | 0.566 (0.314-1.020) | 0.058 | |
| 50-75 | 0.503 (0.216-1.173) | 0.112 | 0.676 (0.284-1.607) | 0.375 | |
| 75-100 | 0.285 (0.140-0.579) | 0.001 | 0.369 (0.179-0.761) | 0.007 | |
| < 0.001a | 0.005a | ||||
| Body pain | 0.005 | 0.017 | |||
| 0-25 (reference) | 1 | 1 | |||
| 25-50 | 0.751 (0.371-1.517) | 0.424 | 0.604 (0.296-1.235) | 0.167 | |
| 50-75 | 0.572 (0.292-1.122) | 0.104 | 0.576 (0.288-1.154) | 0.120 | |
| 75-100 | 0.307 (0.149-0.632) | 0.001 | 0.307 (0.145-0.648) | 0.002 | |
| < 0.001a | 0.002a | ||||
CI, confidence interval; HR, hazard ratio; HRQOL, health-related quality of life.
aP for trend.
Figure 3Patient survival according to the mental health domain elements.
(A) Emotional well-being. (B) Emotional-role limitation. (C) Social function. (D) Energy/fatigue. All HRQOL elements in the mental health domain including (A) emotional well-being (P = 0.281), (B) emotional-role limitation (P = 0.257), (C) social function (P = 0.109), and (D) energy/fatigue (P = 0.294) were not significantly associated with patient survival. Q1, Q2, Q3, Q4, and Q5 means 3- to 5- quantile group as appropriate.
Figure 4Patient survival according to the physical and mental composite scores.
(A) Physical composite score. (B) Mental composite score. Lower physical composite scores (P < 0.001) were significantly associated with poor patient survival. Mental composite scores (P = 0.607) were not associated with patient mortality. Q1, Q2, Q3, Q4, and Q5 means 3- to 5- quantile group as appropriate.
Risk of physical and mental composite score of HRQOL on mortality
| Univariable analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | ||||
| Physical composite score | < 0.001 | 0.003 | |||
| Quartile 1 (reference) | 1 | 1 | |||
| Quartile 2 | 0.454 (0.268-0.768) | 0.003 | 0.535 (0.312-0.916) | 0.023 | |
| Quartile 3 | 0.221 (0.110-0.442) | < 0.001 | 0.326 (0.155-0.685) | 0.003 | |
| Quartile 4 | 0.220 (0.107-0.452) | < 0.001 | 0.357 (0.165-0.771) | 0.009 | |
| < 0.001 | 0.001 | ||||
| Mental composite score | 0.611 | 0.660 | |||
| Quartile 1 (reference) | 1 | 1 | |||
| Quartile 2 | 1.195 (0.670-2.133) | 0.546 | 0.963 (0.532-1.741) | 0.900 | |
| Quartile 3 | 1.086 (0.596-1.976) | 0.788 | 0.900 (0.484-1.674) | 0.740 | |
| Quartile 4 | 0.775 (0.402-1.495) | 0.447 | 0.664 (0.336-1.313) | 0.240 | |
| 0.457 | 0.250 | ||||
CI, confidence interval; HR, hazard ratio; HRQOL, health-related quality of life.
aP for trend.
Adjusted risk of physical and mental composite score of HRQOL on mortality according to age
| Age < 65 years (n = 324) | Age ≥ 65 years (n = 244) | ||||
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | ||||
| Physical composite score | 0.005 | 0.245 | |||
| Quartile 1 (reference) | 1 | 1 | |||
| Quartile 2 | 0.484 (0.179-1.313) | 0.154 | 0.557 (0.284-1.092) | 0.557 | |
| Quartile 3 | 0.121 (0.025-0.598) | 0.010 | 0.497 (0.209-1.181) | 0.113 | |
| Quartile 4 | 0.136 (0.036-0.508) | 0.003 | 0.692 (0.261-1.831) | 0.458 | |
| 0.001 | 0.801 | ||||
| Mental composite score | 0.223 | 0.777 | |||
| Quartile 1 (reference) | 1 | 1 | |||
| Quartile 2 | 1.078 (0.417-2.784) | 0.877 | 0.845 (0.377-1.890) | 0.681 | |
| Quartile 3 | 0.385 (0.115-1.289) | 0.122 | 1.152 (0.517-2.563) | 0.729 | |
| Quartile 4 | 0.420 (0.111-1.584) | 0.200 | 0.817 (0.347-1.920) | 0.642 | |
| 0.071 | 0.858 | ||||
Multivariable Cox analysis was performed after adjusting for age, sex, modified Charlson comorbidity index, and causes of primary kidney disease.
CI, confidence interval; HR, hazard ratio; HRQOL, health-related quality of life.
aP for trend.